Literature DB >> 21199910

Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum.

Catherine M O'Connell1, Yasser M AbdelRahman, Erin Green, Hillary K Darville, Kazima Saira, Bennett Smith, Toni Darville, Amy M Scurlock, Christopher R Meyer, Robert J Belland.   

Abstract

We previously demonstrated that plasmid-deficient Chlamydia muridarum retains the ability to infect the murine genital tract but does not elicit oviduct pathology because it fails to activate Toll-like receptor 2 (TLR2). We derived a plasmid-cured derivative of the human genital isolate Chlamydia trachomatis D/UW-3/Cx, strain CTD153, which also fails to activate TLR2, indicating this virulence phenotype is associated with plasmid loss in both C. trachomatis and C. muridarum. As observed with plasmid-deficient C. muridarum, CTD153 displayed impaired accumulation of glycogen within inclusions. Transcriptional profiling of the plasmid-deficient strains by using custom microarrays identified a conserved group of chromosomal loci, the expression of which was similarly controlled in plasmid-deficient C. muridarum strains CM972 and CM3.1 and plasmid-deficient C. trachomatis CTD153. However, although expression of glycogen synthase, encoded by glgA, was greatly reduced in CTD153, it was unaltered in plasmid-deficient C. muridarum strains. Thus, additional plasmid-associated factors are required for glycogen accumulation by this chlamydial species. Furthermore, in C. trachomatis, glgA and other plasmid-responsive chromosomal loci (PRCLs) were transcriptionally responsive to glucose limitation, indicating that additional regulatory elements may be involved in the coordinated expression of these candidate virulence effectors. Glucose-limited C. trachomatis displayed reduced TLR2 stimulation in an in vitro assay. During human chlamydial infection, glucose limitation may decrease chlamydial virulence through its effects on plasmid-responsive chromosomal genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21199910      PMCID: PMC3067522          DOI: 10.1128/IAI.01118-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNgamma-mediated host cell tryptophan starvation.

Authors:  Scot P Ouellette; Thomas P Hatch; Yasser M AbdelRahman; Lorne A Rose; Robert J Belland; Gerald I Byrne
Journal:  Mol Microbiol       Date:  2006-10-24       Impact factor: 3.501

2.  The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.

Authors:  Zhongyu Li; Ding Chen; Youmin Zhong; Shiping Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

3.  Identification of a Chlamydia trachomatis serovar E urogenital isolate which lacks the cryptic plasmid.

Authors:  D R Stothard; J A Williams; B Van Der Pol; R B Jones
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen.

Authors:  Catherine M O'Connell; Irina A Ionova; Alison J Quayle; Alberto Visintin; Robin R Ingalls
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

5.  A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture.

Authors:  Catherine M O'Connell; Kristy M Nicks
Journal:  Microbiology       Date:  2006-06       Impact factor: 2.777

6.  Glucose metabolism in Chlamydia trachomatis: the 'energy parasite' hypothesis revisited.

Authors:  E R Iliffe-Lee; G McClarty
Journal:  Mol Microbiol       Date:  1999-07       Impact factor: 3.501

7.  The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents.

Authors:  Mark A Pickett; J Sylvia Everson; Patrick J Pead; Ian N Clarke
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

8.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14.

Authors:  Sylvette Bas; Laurence Neff; Madeleine Vuillet; Ursula Spenato; Tsukasa Seya; Misako Matsumoto; Cem Gabay
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

10.  Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease.

Authors:  Catherine M O'Connell; Robin R Ingalls; Charles W Andrews; Amy M Scurlock; Toni Darville
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

View more
  52 in total

1.  Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis.

Authors:  Roger G Rank; Anne K Bowlin; Kati I Tormanen; Yin Wang; Anthony T Maurelli
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

3.  A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.

Authors:  Chunmei Cheng; Pooja Jain; Ilham Bettahi; Sukumar Pal; Delia Tifrea; Luis M de la Maza
Journal:  Vaccine       Date:  2011-07-08       Impact factor: 3.641

4.  Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes.

Authors:  Lihua Song; John H Carlson; William M Whitmire; Laszlo Kari; Kimmo Virtaneva; Daniel E Sturdevant; Heather Watkins; Bing Zhou; Gail L Sturdevant; Stephen F Porcella; Grant McClarty; Harlan D Caldwell
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

5.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

6.  Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.

Authors:  Romina Barral; Ruchi Desai; Xiaojing Zheng; Lauren C Frazer; Gina S Sucato; Catherine L Haggerty; Catherine M O'Connell; Matthew A Zurenski; Toni Darville
Journal:  J Reprod Immunol       Date:  2014-02-01       Impact factor: 4.054

7.  Plasmid-mediated transformation tropism of chlamydial biovars.

Authors:  Lihua Song; John H Carlson; Bing Zhou; Kimmo Virtaneva; William M Whitmire; Gail L Sturdevant; Stephen F Porcella; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2013-11-11       Impact factor: 3.166

8.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01

9.  A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.

Authors:  Chunmei Cheng; Sukumar Pal; Delia Tifrea; Zhenyu Jia; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-11-27       Impact factor: 2.700

10.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.